Birdwatch Archive

Birdwatch Note Rating

2025-06-06 15:51:46 UTC - NOT_HELPFUL

Rated by Participant: B188C045C19ACE4A87961ADFD401B930527AAD838E3C4CD78CCD6F02EDBD2214
Participant Details

Original Note:

Remdesivir did not increase risk of death from Ebola, but it was inferior to other studied treatments in the treatment of Ebola. About 53% of patients receiving remdesivir died from Ebola in the trial compared to 35% with the superior therapeutics. https://www.nih.gov/news-events/news-releases/investigational-drugs-reduce-risk-death-ebola-virus-disease https://pmc.ncbi.nlm.nih.gov/articles/PMC7250494

All Note Details

Original Tweet

All Information

  • noteId - 1930974457620771321
  • participantId -
  • raterParticipantId - B188C045C19ACE4A87961ADFD401B930527AAD838E3C4CD78CCD6F02EDBD2214
  • createdAtMillis - 1749225106482
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - NOT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 1
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 1
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 1
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 1
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 1
  • ratingsId - 1930974457620771321B188C045C19ACE4A87961ADFD401B930527AAD838E3C4CD78CCD6F02EDBD2214